Read more
17:12 · 26 February 2026

D‑Wave Quantum: Concrete Results Today, Big Dreams Tomorrow

-
-
Open account Download free app

D‑Wave Quantum reported its results for the fourth quarter of fiscal year 2025, showing both dynamic business growth and certain operational challenges. During this period, the company recorded revenues of approximately 2.8 million USD, representing a 19 percent increase compared to the same period last year, yet falling short of analysts’ expectations. At the same time, earnings per share were below forecasts, which further influenced investors’ assessment of the results.

For the full year 2025, D‑Wave delivered much more impressive results. Annual revenues reached approximately 24.6 million USD, representing a 179 percent increase compared to the previous year, with gross margin improving to over 82 percent. The company ended the year with a record cash position of approximately 884 million USD, providing significant financial flexibility for further investments in technology development and client relationship building.

Key financial highlights:

  • Quarterly revenues: approximately 2.8 million USD, up 19 percent year-over-year, below expectations

  • Earnings per share (EPS): below analysts’ forecasts

  • Annual revenues: approximately 24.6 million USD, up 179 percent year-over-year

  • Gross margin: over 82 percent

  • Cash position: approximately 884 million USD

  • New orders in Q4: up 471 percent compared to the previous quarter

  • Preliminary orders for 2026: over 32 million USD

Despite positive trends in revenues and new orders, the company continues to report significant operating losses due to intensive investments in research, development, and marketing aimed at accelerating the commercialization of its technology. The quantum technology market remains in its early development phase, and competitive advantages are not yet fully reflected in actual revenues. D‑Wave’s stock valuation is largely based on expectations for future technological success, making the share price subject to high volatility and sensitive to short-term performance results.

The company is also executing strategic contracts, such as the sale of a quantum system to a university for approximately 20 million USD, demonstrating that real-world applications of quantum technology are gradually starting to materialize.

D‑Wave Quantum is a company with clear growth potential, driven by rapidly increasing annual revenues, a record cash position, and rising demand for quantum technologies. At the same time, ongoing operating losses, uncertainty regarding the pace of commercialization, and a high market valuation mean that investments in the company’s shares carry significant short-term risk.

In the broader industry context, it should be noted that quantum companies are still at the very beginning of their development cycle and can be compared to the artificial intelligence market around 2017. Full commercialization of quantum technologies is likely to occur only in the 2030s, and most companies that survive until then may only become profitable at that time. This means that investments in such companies are primarily long-term, with the potential for significant future gains, but also with a high level of risk in the current market cycle.

 

Source: xStation5

 

6 April 2026, 17:24

Wall Street rebound continues ahead of the US open 📈Netflix surges on Goldman Sachs upgrade

3 April 2026, 14:31

DAX down 12% from all-time high 🚩Watch this 2 stocks in April

2 April 2026, 21:32

Daily summary: Hopes for peace and space stocks in the spotlight

2 April 2026, 20:58

Globalstar: Are we headed for a battle of giants over orbit?

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer are risky. XTB is regulated by the CMA.